Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if HYPD is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
5 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 5
33 filers reported a long position in HYPD for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1.5M | 466.8K | +453% |
| FRANKLIN RESOURCES INC | $1.2M | 395.9K | New |
| Arrington Capital Management, LLC | $935K | 297.8K | New |
| MORGAN STANLEY | $747.3K | 238K | Unchanged |
| Almanack Investment Partners, LLC. | $530.7K | 169K | New |
| GEODE CAPITAL MANAGEMENT, LLC | $410.5K | 130.7K | +69.6% |
| JANE STREET GROUP, LLC | $400.3K | 127.5K | -0.6% |
| OPPENHEIMER & CO INC | $396.8K | 126.4K | +96.6% |
| BlackRock, Inc. | $359.2K | 114.4K | +41% |
| GOLDMAN SACHS GROUP INC | $287K | 91.4K | New |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.